Shots:
- Following FDA 510(k) clearance, Mentice has launched Ankyras 4.0 for pts-specific flow diverter planning to treat intracranial aneurysms in the US
- Ankyras 4.0 introduces DICOM node integration, a redesigned user interface & broader accessibility via online platform & mobile apps, plus its integration with VIST simulation allows virtual case rehearsal to accelerate decision-making & improve collaboration on-site or remotely
- Ankyras is a neurovascular decision-support tool that helps clinical teams plan, size, & simulate flow diverter treatments for intracranial aneurysms using pts-specific vascular models, improving confidence in sizing, placement, & procedural strategy before entering the angiosuite
Ref: Mentice | Image: Mentice
Related News:- Johnson & Johnson MedTech Launches Cereglide 92 Catheter System in the US for Acute Ischemic Stroke
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click Here for Full Press Release
